Theriva Biologics, Inc. (TOVX)
0.249
0.00 (0.00%)
USD |
NYAM |
Sep 01, 16:00
0.249
0.00 (0.00%)
After-Hours: 16:32
Theriva Biologics Total Long Term Debt (Quarterly) : 3.028M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.028M |
| March 31, 2026 | 3.183M |
| December 31, 2025 | 2.08M |
| September 30, 2025 | 2.144M |
| June 30, 2025 | 2.279M |
| March 31, 2025 | 2.287M |
| December 31, 2024 | 1.026M |
| September 30, 2024 | 1.198M |
| June 30, 2024 | 1.317M |
| March 31, 2024 | 1.52M |
| December 31, 2023 | 1.667M |
| September 30, 2023 | 1.761M |
| June 30, 2023 | 1.904M |
| March 31, 2023 | 2.028M |
| December 31, 2022 | 1.465M |
| September 30, 2022 | 1.498M |
| June 30, 2022 | 1.57M |
| March 31, 2022 | 1.648M |
| December 31, 2021 | 1.403M |
| September 30, 2021 | 1.401M |
| June 30, 2021 | 1.426M |
| March 31, 2021 | 0.108M |
| December 31, 2020 | 0.186M |
| September 30, 2020 | 0.261M |
| June 30, 2020 | 0.334M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.405M |
| December 31, 2019 | 0.473M |
| September 30, 2019 | 0.539M |
| June 30, 2019 | 0.601M |
| March 31, 2019 | 0.662M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Nkarta, Inc. | 66.26M |
| Unicycive Therapeutics, Inc. | 0.055M |
| OnKure Therapeutics, Inc. | 0.59M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |